European Journal of Gastroenterology and Hepatology 1997-04-01

Tenoxicam-associated hepatic injury: a case report and review.

P Katsinelos, I Katsos, K Patsiaoura, P Xiarchos, I Goulis, N Eugenidis

Index: Eur. J. Gastroenterol. Hepatol. 9(4) , 403-6, (1997)

Full Text: HTML

Abstract

A 51-year-old woman developed jaundice while taking tenoxicam. A full evaluation, including ultrasound, computed tomography, endoscopic cholangiography and liver biopsy, confirmed the diagnosis of mixed hepatic injury. The patient's jaundice and all other liver function abnormalities normalized 1 month after she discontinued taking tenoxicam. This is the first case report of mixed hepatic injury, confirmed with biopsy, associated with tenoxicam. Tenoxicam should be considered as a potential cause of hepatic injury when other more common aetiologies have been excluded.

Related Compounds

  • Tenoxicam

Related Articles:

Semi solid matrix formulations of meloxicam and tenoxicam: an in vitro and in vivo evaluation.

2015-01-01

[Arch. Pharm. Res. 38 , 801-12, (2015)]

[Turbidimetric determination of tenoxicam using molybdophosphoric acid].

2010-01-01

[Rev. Med. Chir. Soc. Med. Nat. Iasi. 114(1) , 249-54, (2010)]

Effect of age on the pharmacokinetics of tenoxicam in comparison to other non-steroidal anti-inflammatory drugs (NSAIDs).

1989-01-01

[Scand. J. Rheumatol. Suppl. 80 , 86-9, (1989)]

Determination of pKavalues of tenoxicam from1H NMR chemical shifts and of oxicams from electrophoretic mobilities (CZE) with the aid of programs SQUAD and HYPNMR

2009-01-01

[Talanta 80(2) , 754-62, (2009)]

Comparing the efficacy of intravenous tenoxicam, lornoxicam, and dexketoprofen trometamol for the treatment of renal colic.

2012-10-01

[Am. J. Emerg. Med. 30(8) , 1486-90, (2012)]

More Articles...